Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1

Tight regulation of transcription factors, such as PU.1, is crucial for generation of all hematopoietic lineages. We previously reported that mice with a deletion of an upstream regulatory element (URE) of the gene encoding PU.1 (Sfpi1) developed acute myeloid leukemia. Here we show that the URE has an essential role in orchestrating the dynamic PU.1 expression pattern required for lymphoid development and tumor suppression. URE deletion ablated B2 cells but stimulated growth of B1 cells in mice. The URE was a PU.1 enhancer in B cells but a repressor in T cell precursors. TCF transcription factors coordinated this repressor function and linked PU.1 to Wnt signaling. Failure of appropriate PU.1 repression in T cell progenitors with URE deletion disrupted differentiation and induced thymic transformation. Genome-wide DNA methylation assessment showed that epigenetic silencing of selective tumor suppressor genes completed PU.1-initiated transformation of lymphoid progenitors with URE deletion. These results elucidate how a single transcription factor, PU.1, through the cell context–specific activity of a key cis-regulatory element, affects the development of multiple cell lineages and can induce cancer.

[1]  L. Herzenberg.  B‐1 cells: the lineage question revisited , 2000, Immunological reviews.

[2]  L. Herzenberg,et al.  Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. Vainchenker,et al.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias , 1996, Molecular and cellular biology.

[4]  R. Takahashi,et al.  Calpain-mediated X-linked Inhibitor of Apoptosis Degradation in Neutrophil Apoptosis and Its Impairment in Chronic Neutrophilic Leukemia* , 2002, The Journal of Biological Chemistry.

[5]  F. Moreau-Gachelin,et al.  Spi-1 is a putative oncogene in virally induced murine erythroleukaemias , 1988, Nature.

[6]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[7]  D. Tenen,et al.  Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b , 2006, Oncogene.

[8]  J. Waring,et al.  Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.

[9]  Stuart H. Orkin,et al.  Diversification of haematopoietic stem cells to specific lineages , 2000, Nature Reviews Genetics.

[10]  H. Singh,et al.  Regulation of B lymphocyte and macrophage development by graded expression of PU.1. , 2000, Science.

[11]  J. Licht,et al.  Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.

[12]  Wei Ding,et al.  Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia , 2005, Nature Genetics.

[13]  A. Rolink,et al.  The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential. , 2005, Blood.

[14]  Pu Zhang,et al.  Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element , 2005, Molecular and Cellular Biology.

[15]  M. Israel,et al.  Id4 expression induces apoptosis in astrocytic cultures and is down-regulated by activation of the cAMP-dependent signal transduction pathway. , 1999, Experimental cell research.

[16]  J. Kawai,et al.  Accessibility to tissue‐specific genes from methylation profiles of mouse brain genomic DNA , 1995, Electrophoresis.

[17]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[18]  R. Berland,et al.  Origins and functions of B-1 cells with notes on the role of CD5. , 2002, Annual review of immunology.

[19]  Ellen V Rothenberg,et al.  Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. , 2002, Immunity.

[20]  G. M. Fischer,et al.  Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. , 2001, Cellular immunology.

[21]  E. Scott,et al.  The ETS family transcription factor PU.1 is necessary for the maintenance of fetal liver hematopoietic stem cells. , 2004, Blood.

[22]  R. Ceredig,et al.  A positive look at double-negative thymocytes , 2002, Nature Reviews Immunology.

[23]  Thomas M. Schmitt,et al.  Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. , 2002, Immunity.

[24]  M. Caligiuri,et al.  A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. , 2004, Genomics.

[25]  F. Rosenbauer,et al.  Effect of transcription-factor concentrations on leukemic stem cells. , 2005, Blood.

[26]  J. Kutok,et al.  Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1 , 2004, Nature Genetics.

[27]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[28]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Harinder Singh,et al.  Contingent gene regulatory networks and B cell fate specification. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Morris,et al.  Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes , 1993, The Journal of experimental medicine.

[31]  M. Klemsz,et al.  DNA methylation and chromatin structure regulate PU.1 expression. , 1999, DNA and cell biology.

[32]  Reynaldo Sequerra,et al.  High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP , 2000, Nature Genetics.

[33]  Li Wu,et al.  PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis , 2005, The Journal of experimental medicine.

[34]  Jianzhu Chen,et al.  Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. , 1998, Journal of immunology.

[35]  T. Graubert,et al.  Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. , 2003, Experimental hematology.

[36]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[37]  Richard Dahl,et al.  Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPα ratio and granulocyte colony-stimulating factor , 2003, Nature Immunology.

[38]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[39]  H C Clevers,et al.  Critical involvement of Tcf-1 in expansion of thymocytes. , 1998, Journal of immunology.

[40]  M. Gobbi,et al.  Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia , 1982, The Journal of experimental medicine.

[41]  K. Akashi,et al.  Regulation of the PU.1 gene by distal elements. , 2001, Blood.

[42]  F. Rosenbauer,et al.  pDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU.1. , 2004, Blood.

[43]  M. Taketo,et al.  Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene , 1999, The EMBO journal.

[44]  T. Rothstein.  Cutting Edge Commentary: Two B-1 or Not To Be One1 , 2002, The Journal of Immunology.

[45]  K. Wolff,et al.  Fibroblast Growth Factor-2 Induces Lef/Tcf-dependent Transcription in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[46]  S. So,et al.  Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma , 2003, Oncogene.

[47]  Robert B Boxer,et al.  Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. , 2004, Cancer cell.

[48]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[49]  K. Akashi,et al.  Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. , 2005, Blood.